Clinical Trial: Effect of Recombinant Human Brain Natriuretic Peptide on Coronary Microvascular Function in Patients Undergoing Coronary Artery Rotational Atherectomy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Recombinant Human Brain Natriuretic Peptide on Coronary Microvascular Function in Patients Undergoing Coronary Artery Rotational Atherectomy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130272

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338884

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Effect of Recombinant Human Brain Natriuretic Peptide on Coronary Microvascular Function in Patients Undergoing Coronary Artery Rotational Atherectomy: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study (China)